FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2207982014> ?p ?o ?g. }

• W2207982014 endingPage "70" @default.
• W2207982014 startingPage "463" @default.
• W2207982014 abstract "The carcinogenesis process is characterized, in part, by the dysfunction of cellular communication pathways, such as the one involving HER2. HER2 is a member of the EGF receptor family, which participates in cell growth and proliferation. HER2 may be overexpressed in 15 to 30% of breast cancer cases and is associated with poor prognosis, shortened overall survival and shorter time to disease progression. Furthermore, an increasing number of studies have demonstrated the relevance of HER2 serum concentrations (sHER2, extracellular domain released into blood by proteolysis) as a predictive marker of resistance to chemotherapy in HER2-overexpressing metastatic breast cancer. The determination of HER2 overexpression/ amplification in the diagnosis of relapse of breast cancer is currently a routine procedure. Immunohistochemistry (IHC) and fluorescent in situ hybridization (FISH) techniques, which are used to detect HER2 expression in the tumor, are improving constantly, and other parallel techniques such as chromogenic in situ hybridization (CISH) are starting to emerge. sHER2 concentrations can be measured using ELISA techniques, which can be automated. All of these procedures still need to be standardized. The discovery of a monoclonal antibody (4D5) that can inhibit the growth and proliferation of cells overexpressing HER2 led to the development of trastuzumab. Like 4D5, trastuzumab recognizes an epitope on the extracellular domain of HER2. Moreover, trastuzumab is also able to stimulate antibody-dependent cellular toxicity (ADCC). It is administered alone or in combination (with navelbine, taxol, carboplatin...) in patients with metastatic breast cancer overexpressing HER2. Other active antibodies have since been discovered, as well as other specific molecules, such as tyrosine kinase inhibitors which will undoubtedly find a place in the therapeutic arsenal used in breast cancer, especially to avoid the emergence of resistance to treatment." @default.
• W2207982014 created "2016-06-24" @default.
• W2207982014 creator A5015474692 @default.
• W2207982014 creator A5019071610 @default.
• W2207982014 creator A5030869013 @default.
• W2207982014 creator A5042610778 @default.
• W2207982014 creator A5071867163 @default.
• W2207982014 creator A5074747542 @default.
• W2207982014 creator A5077244706 @default.
• W2207982014 date "2006-06-03" @default.
• W2207982014 modified "2023-09-26" @default.
• W2207982014 title "Prospect for anti-HER2 receptor therapy in breast cancer." @default.
• W2207982014 cites W1574463874 @default.
• W2207982014 cites W1593325979 @default.
• W2207982014 cites W1867197625 @default.
• W2207982014 cites W1877098097 @default.
• W2207982014 cites W1928718614 @default.
• W2207982014 cites W1965755761 @default.
• W2207982014 cites W1967226516 @default.
• W2207982014 cites W1973033337 @default.
• W2207982014 cites W1973555911 @default.
• W2207982014 cites W1986214131 @default.
• W2207982014 cites W1996372431 @default.
• W2207982014 cites W1999329028 @default.
• W2207982014 cites W2001961750 @default.
• W2207982014 cites W2003792276 @default.
• W2207982014 cites W2007256480 @default.
• W2207982014 cites W2014131622 @default.
• W2207982014 cites W2014909020 @default.
• W2207982014 cites W2029385817 @default.
• W2207982014 cites W2035484878 @default.
• W2207982014 cites W2040111991 @default.
• W2207982014 cites W2043711125 @default.
• W2207982014 cites W2054430764 @default.
• W2207982014 cites W2060577729 @default.
• W2207982014 cites W2067276829 @default.
• W2207982014 cites W2082117763 @default.
• W2207982014 cites W2083982805 @default.
• W2207982014 cites W2092229345 @default.
• W2207982014 cites W2092429540 @default.
• W2207982014 cites W2093153734 @default.
• W2207982014 cites W2098544382 @default.
• W2207982014 cites W2099113749 @default.
• W2207982014 cites W2100723992 @default.
• W2207982014 cites W2114974083 @default.
• W2207982014 cites W2117115931 @default.
• W2207982014 cites W2121954422 @default.
• W2207982014 cites W2123646476 @default.
• W2207982014 cites W2125785648 @default.
• W2207982014 cites W2126619703 @default.
• W2207982014 cites W2130074283 @default.
• W2207982014 cites W2130923413 @default.
• W2207982014 cites W2131851186 @default.
• W2207982014 cites W2137008427 @default.
• W2207982014 cites W2139135964 @default.
• W2207982014 cites W2141217952 @default.
• W2207982014 cites W2141393790 @default.
• W2207982014 cites W2145390117 @default.
• W2207982014 cites W2146406055 @default.
• W2207982014 cites W2146681242 @default.
• W2207982014 cites W2146689490 @default.
• W2207982014 cites W2147529602 @default.
• W2207982014 cites W2148689234 @default.
• W2207982014 cites W2153024287 @default.
• W2207982014 cites W2153130468 @default.
• W2207982014 cites W2154027407 @default.
• W2207982014 cites W2159363679 @default.
• W2207982014 cites W2161428561 @default.
• W2207982014 cites W2169679536 @default.
• W2207982014 cites W2169782526 @default.
• W2207982014 cites W2222638000 @default.
• W2207982014 cites W2262099091 @default.
• W2207982014 cites W2318605753 @default.
• W2207982014 cites W286624791 @default.
• W2207982014 cites W47013412 @default.
• W2207982014 cites W2122076391 @default.
• W2207982014 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16739343" @default.
• W2207982014 hasPublicationYear "2006" @default.
• W2207982014 type Work @default.
• W2207982014 sameAs 2207982014 @default.
• W2207982014 citedByCount "13" @default.
• W2207982014 countsByYear W22079820142012 @default.
• W2207982014 countsByYear W22079820142013 @default.
• W2207982014 countsByYear W22079820142014 @default.
• W2207982014 countsByYear W22079820142016 @default.
• W2207982014 countsByYear W22079820142019 @default.
• W2207982014 countsByYear W22079820142022 @default.
• W2207982014 crossrefType "journal-article" @default.
• W2207982014 hasAuthorship W2207982014A5015474692 @default.
• W2207982014 hasAuthorship W2207982014A5019071610 @default.
• W2207982014 hasAuthorship W2207982014A5030869013 @default.
• W2207982014 hasAuthorship W2207982014A5042610778 @default.
• W2207982014 hasAuthorship W2207982014A5071867163 @default.
• W2207982014 hasAuthorship W2207982014A5074747542 @default.
• W2207982014 hasAuthorship W2207982014A5077244706 @default.
• W2207982014 hasConcept C104317684 @default.
• W2207982014 hasConcept C121313828 @default.
• W2207982014 hasConcept C121608353 @default.

• next